Page 47 - Performance Share Plan News Today

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

  Just Eat Takeaway.com (LSE: JET, AMS: TKWY) is a leading global online food delivery marketplace outside China.   Headquartered in Amsterdam, the Company is focused on connecting consumers and restaurants through its platforms. With over 205,000 connected restaurants, Just Eat Takeaway.com offers consumers a wide variety of food choice. Just Eat Takeaway.com mainly collaborates with delivery restaurants. In addition, Just Eat Takeaway.com provides its proprietary restaurant delivery service...

  Shield is a de-risked, specialty pharmaceutical company focused on commercialising its lead product, Feraccru®/Accrufer®, a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anaemia. Feraccru®/Accrufer® has been approved for use in the United States, European Union, UK and Switzerland and has exclusive IP rights until the mid-2030s. Feraccru is commercialised in the UK and Europe by Norgine B.V. and the Company is currently in the proc...

  Shield is a de-risked, specialty pharmaceutical company focused on commercialising its lead product, Feraccru®/Accrufer®, a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anaemia. Feraccru®/Accrufer® has been approved for use in the United States, European Union, UK and Switzerland and has exclusive IP rights until the mid-2030s. Feraccru is commercialised in the UK and Europe by Norgine B.V. and the Company is currently in the proc...

Vaisalas Board of Directors resolved on a long-term Performance Share Plan Vaisalas Board of Directors approved a Performance Share Plan for companys key employees. The aim of the long-term plan is to align the objectives of Vaisalas shareholders and key employees in order to increase the value of the company in the long-term and commit key employees to the company.   The potential rewards from the Performance Share Plan 2021–2023 will be based on the Total Shareholder Return of Vaisalas sh...

(2) Valmet Oyjs stock exchange release on December 17, 2020 at 1:00 p.m. EET HELSINKI, Dec. 17, 2020 /PRNewswire/ -- The Board of Directors of Valmet Oyj has decided on new share-based long-term incentive plans (LTI Plans), a Performance Share Plan and a Deferred Share Plan, as well as a restricted shares pool (Restricted Pool) for Valmets key employees. The aim of the plans is to align the interests of the shareholders and the key employees in order to increase the value of Valmet Oyj (the Com...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

Vaisala Group: Vaisalas Board of Directors resolved on a long-term Performance Share Plan Vaisalas Board of Directors resolved on a long-term Performance Share Plan Vaisalas Board of Directors approved a Performance Share Plan for companys key employees. The aim of the long-term plan is to align the objectives of Vaisalas shareholders and key employees in order to increase the value of the company in the long-term and commit key employees to the company. The potential rewards from the Performan...

Enento Group Oyj: The Board of Directors of Enento Group resolved on a long-term incentive plan for key personnel The Board of Directors of Enento Group resolved on a long-term incentive plan for key personnel The Board of Directors of Enento Group Plc has decided on a new share-based incentive plan for its key personnel for 2021 -2023. This he Performance Share Plan plan is based on the similar plan launched last year. The intention is to continue launching new long-term incentive plans annual...